You're watching...
Merck Tops Analysts Estimates
Details
-
Description
FBN’s Diane Macedo breaks down MRK’s fourth-quarter earnings report.
- Duration 0:15
- Date Feb 1, 2013
Advertisement
Clips
Also in this playlist...
Latest Video
Auto-advance: ON
Auto-advance-
Can Government Make RICO Case Against SAC Capital?
-
Will IRS Scandal Speed Up Tax Reform?
-
Time for White House to Stop Waffling on Keystone?
-
House Putting Pressure on President to Approve Keystone?
-
The Battle to Renovate Nassau Coliseum
-
AutoNation CEO: Autos in Recovery That Will Go on for Years
-
Where are the Buying Opportunities in the Market?
-
FINRA Adds Oversight of 2 More Exchanges
-
Hewlett-Packard 2Q Earnings Top Estimates
-
Housing Data Boost Shares of Toll Brothers
-
The Benefits of 3D Printing Technology
-
Wayne Angell: I Remain Very Bullish About This Market
Transcript
This transcript is automatically generated
We're getting earnings in from Merck now the drugmaker.
Three cents a share that cops that the estimate for 81 cents revenue came in at eleven point seven billion dollars that was also be.
Analysts were expecting eleven point 48 billion let's take a look.
Trending
-
The Battle to Renovate Nassau Coliseum
-
House Putting Pressure on President to Approve Keystone?
-
Wayne Angell: I Remain Very Bullish About This Market
-
Time for White House to Stop Waffling on Keystone?
-
Should Trades Like Plumbing Be Encouraged More?
-
AutoNation CEO: Autos in Recovery That Will Go on for Years